A
Adnan Tufail
Researcher at Moorfields Eye Hospital
Publications - 274
Citations - 12126
Adnan Tufail is an academic researcher from Moorfields Eye Hospital. The author has contributed to research in topics: Macular degeneration & Visual acuity. The author has an hindex of 52, co-authored 256 publications receiving 9323 citations. Previous affiliations of Adnan Tufail include UCL Institute of Ophthalmology & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Evaluation of Nonperfused Retinal Vessels in Ischemic Retinopathy
Michael B. Powner,Dawn A Sim,Meidong Zhu,João Nobre-Cardoso,Ryan Jones,Adil Syed,Andrew Chang,Pearse A. Keane,Adnan Tufail,Catherine A Egan,Marcus Fruttiger +10 more
TL;DR: The data suggests long-term preservation of vascular basement membrane in ischemic retina in patients suffering from retinal vascular occlusions, which has implications for therapeutic approaches aiming to alleviate retinal ischemia via the regeneration of damaged vessels.
Journal ArticleDOI
Visual acuity loss in patients with age-related macular degeneration measured using a novel high-pass letter chart
TL;DR: VA measurements with the MAC chart appear to be more sensitive to functional loss in AMD compared with conventional letter charts, with similar TRV, Simulations indicate this may be because the high-pass filtered letters are more vulnerable to undersampling as a result of retinal cell loss in the disease process.
Journal ArticleDOI
Two‐year results of surgical removal of choroidal neovascular membranes related to non‐age‐related macular degeneration
TL;DR: Surgical excision of non-AMD-related CNV resulted in improvement of VA in the majority of eyes, and worse presenting acuity was associated with better visual improvements, while no evidence of association between 2-year visual outcome and any other baseline factor under study was observed.
Journal ArticleDOI
Intersession repeatability of contrast sensitivity scores in age-related macular degeneration.
TL;DR: Although a change criterion of six or more letters may be an adequate end point in clinical trials for patients with early AMD, a larger change criterion may be necessary for clinical trials of patients with late AMD.
Journal ArticleDOI
Optical Coherence Tomography Features Of Active And Inactive Retinal Neovascularization In Proliferative Diabetic Retinopathy
Sara Vaz-Pereira,Javier Zarranz-Ventura,Dawn A Sim,Pearse A. Keane,Rebecca Smith,Catherine A Egan,Adnan Tufail +6 more
TL;DR: Spectral domain-optical coherence tomography features of retinal neovascularization in proliferative diabetic retinopathy and thus to identify novel signs of new vessel activity were described and the presence of vitreous hyperreflective dots, epiretinal membrane, inner retinal tissue contracture, Vitreous invasion, and vitreOUS protrusion were identified as distinct signs of disease activity.